CAPTOPRIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Captopril, and when can generic versions of Captopril launch?
Captopril is a drug marketed by Ajanta Pharma Ltd, Andas 5 Holding, Apothecon, Aurobindo Pharma Usa, Changzhou Pharm, Chartwell Rx, Corepharma, Cosette, Dava Pharms Inc, Egis Pharms, G And W Labs Inc, Hikma Intl Pharms, Oxford Pharms, Prinston Inc, Purepac Pharm, Sandoz, Seton Pharms, Strides Pharma, Teva, Watson Labs, Wockhardt, Ivax Sub Teva Pharms, and Rising. and is included in thirty-one NDAs.
The generic ingredient in CAPTOPRIL is captopril; hydrochlorothiazide. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the captopril; hydrochlorothiazide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Captopril
A generic version of CAPTOPRIL was approved as captopril; hydrochlorothiazide by RISING on December 29th, 1997.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CAPTOPRIL?
- What are the global sales for CAPTOPRIL?
- What is Average Wholesale Price for CAPTOPRIL?
Summary for CAPTOPRIL
| US Patents: | 0 |
| Applicants: | 23 |
| NDAs: | 31 |
| Finished Product Suppliers / Packagers: | 13 |
| Raw Ingredient (Bulk) Api Vendors: | 118 |
| Clinical Trials: | 50 |
| Drug Prices: | Drug price information for CAPTOPRIL |
| DailyMed Link: | CAPTOPRIL at DailyMed |
Recent Clinical Trials for CAPTOPRIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Natural Wellness Egypt | Phase 3 |
| Shanghai Jiao Tong University School of Medicine | Phase 4 |
| Iain Bressendorff | Phase 2 |
Pharmacology for CAPTOPRIL
| Drug Class | Angiotensin Converting Enzyme Inhibitor |
| Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
Medical Subject Heading (MeSH) Categories for CAPTOPRIL
Anatomical Therapeutic Chemical (ATC) Classes for CAPTOPRIL
US Patents and Regulatory Information for CAPTOPRIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Purepac Pharm | CAPTOPRIL | captopril | TABLET;ORAL | 074640-004 | Mar 31, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wockhardt | CAPTOPRIL | captopril | TABLET;ORAL | 074532-001 | Mar 28, 1997 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Cosette | CAPTOPRIL | captopril | TABLET;ORAL | 074483-003 | Feb 13, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Corepharma | CAPTOPRIL | captopril | TABLET;ORAL | 074737-004 | Oct 28, 1998 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
